Are you a practitioner?

Join our network
join us illustration
Rheumatologist
Χρήστος Γκαμαλούτσος Rheumatologist: Book an online appointment

Γκαμαλούτσος Χρήστος

Rheumatologist Pagrati

Location

Υμηττού 86, Pagrati, Attica

Next availability
Check availability

Why he is suitable for you

Ο Χρήστος Γκαμαλούτσος είναι ιατρός Ρευματολόγος και διατηρεί ιδιωτικό ιατρείο στο Παγκράτι, όπου παρέχει εξατομικευμένη φροντίδα πάνω στη διάγνωση, αντιμετώπιση και παρακολούθηση των ρευματικών και αυτοάνοσων νοσημάτων. Είναι απόφοιτος του Τμήματος Ιατρικής του Αριστοτελείου Πανεπιστημίου Θεσσαλονίκης, και έχει εξειδικευτεί στη Ρευματολογία στο Γενικό Νοσοκομείο Αθηνών «Ο Ευαγγελισμός». Παράλληλα, διαθέτει σημαντική επαγγελματική εμπειρία στη φαρμακευτική βιομηχανία, έχοντας αναλάβει θέσεις αυξημένης ευθύνης στον τομέα της κλινικής έρευνας. Η κλινική εμπειρία και η ενασχόληση με την κλινική έρευνα, σε συνδυασμό με τη συνεχή επιστημονική ενημέρωση, διαμορφώνουν μια σύγχρονη και τεκμηριωμένη ιατρική προσέγγιση με βασική προτεραιότητα την εξατομικευμένη φροντίδα κάθε ασθενούς και τη βελτίωση της ποιότητας ζωής του.

The description was edited by the doctoranytime team, based on verified information.

Experience

Relative Experience

  • Autoimmune diseases
  • Intra-articular injections
  • Rheumatic diseases

Availability

The specialist's availability depends on the service you select.

Υμηττού 86, Pagrati, Attica

Next availability

Services

Costs are indicative and will be determined on a case by case basis

Contact and location

    • Address
      Υμηττού 86, Pagrati, Attica
    • Metro
      • 940m ΕΥΑΓΓΕΛΙΣΜΟΣ
      • 1,06km ΜΕΓΑΡΟ ΜΟΥΣΙΚΗΣ
    • Bus
      • 40m ΔΗΜΑΡΧΕΙΟ
      • 140m ΠΟΣΕΙΔΩΝΑΣ
      • 150m ΚΟΝΩΝΟΣ
    • Parking
      • 720m HILTON
      • 900m ΣΤΑΘΜΟΣ ΡΙΖΑΡΗ
      • 1,36km ΜΕΓΑΡΟ ΜΟΥΣΙΚΗΣ ΑΘΗΝΩΝ
Could not find any practice in map.

Payment Methods

  • Payment Methods

    • Bank Card
    • Cash

    Appointment Policy

    • Payment at the practice

      During your visit, you can select the payment method of your choice from the options mentioned above.

    • Cancellation

      You can always cancel up to 3 hours before the appointment. For more information please read our cancellation policy.

Curriculum Vitae and Career

Studies

  • Ειδίκευση στη Ρευματολογία, Ρευματολογική Κλινική, Γενικό Νοσοκομείο Αθηνών ¨Ο Ευαγγελισμός¨ (2007 - 2011)
  • Ειδικότητα Ρευματολογίας - Παθολογία, Παθολογική Κλινική, 7ο Νοσοκομείο ΙΚΑ (2004 - 2006)
  • Πτυχίο Ιατρικής, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (1994 - 2000)

Professional experience

  • Ειδικός Ρευματολόγος, Ιδιωτικό Ιατρείο, Παγκράτι (2011 - Σήμερα)
  • Medical Director Greece & Cyprus, Solutions for Rare Diseases (2025 - Σήμερα)
  • Evidence Generation & Medical Compliance Lead , Johnson & Johnson Innovative Medicine, Greece (2022 - 2025)
  • Επιστημονικός Συνεργάτης, Λοιμωξιολογικό Τμήμα, Ιατρικό Κέντρο Αθηνών (2006 - 2007)

Organisations member

  • Ιατρικός Σύλλογος Αθηνών
  • Ελληνική Ρευματολογική Εταιρεία
  • Επιστημονική Εταιρεία για τη Μυοσκελετική Υγεία

Academic research and publications

  • Psoriasis Impact on Patient-Reported Outcomes in Psoriatic Arthritis in a Real-World Setting: Results from the APOPSIS study. Athanassiou P, Theodoridou A, Koukli EM, Georgountzos A, Vlachoyiannopoulos P, Kallitsakis I, Sakkas L, Matsouka Dapola A, Gazi S, Georgiou P, Gorecki P, Gkamaloutsos C. Poster presented at ACR 2019. (2019)
  • USTEKINUMAB AND TNF INHIBITORS IN GREEK PATIENTS WITH PSORIATIC ARTHRITIS. FIRST FOLLOW UP DATA FROM THE ROUTINE CARE STUDY PSABIO. P. Sfikakis, P. Athanasiou, G. Katsifis, P. Vlachogiannopoulos, Α. Georgountzos, D. Boumpas, L. Sakkas, Α. Garyfallos, P. Sidiropoulos, P. Georgiou, D. Vasilopoulos, D. Kassimos, C. Gkamaloutsos, E. Theander, P. Bergmans, P. Smirnov, L. Gossec, J. S. Smolen. Poster presented at the 25th Panhellenic Rheumatology Congress, Athens, 2016. (2016)
  • BIOLOGIC DMARDS AND PSORIATIC ARTHRITIS IN GREECE IN 2016/2017: CHARACTERISTICS OF GREEK PATIENTS STARTING TNF-INHIBITORS OR USTEKINUMAB IN THE ONGOING PSABIO OBSERVATIONAL COHORT STUDY. P. Sfikakis, P. Athanasiou, G. Katsifis, P. Vlachogiannopoulos, Α. Georgountzos, D. Boumpas, L. Sakkas, Α. Garyfallos, P. Sidiropoulos, P. Georgiou, D. Vasilopoulos, D. Kassimos, C. Gkamaloutsos, E. Theander, P. Bergmans, P. Smirnov, J. S. Smolen, L. Gossec. Poster presented at the 25th Panhellenic Rheumatology Congress, Athens, 2016. (2016)
  • Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. Chatzistamatiou TK1, Papassavas AC, Michalopoulos E, Gamaloutsos C, Mallis P, Gontika I, Panagouli E, Koussoulakos SL, Stavropoulos-Giokas C. Transfusion. 2014 Dec;54(12):3108-20 (2014)
  • Baseline characteristics of disease, patients and treatment with ustekinumab for Crohn’s Disease in Greece: 12-month interim analysis results of ‘REASSURE’ study. S. Michopoulos, C. Gkamaloutsos, M. Tzouvala, G Bamias, V. Xourgias, D. Christodoulou, C. Liatsos, S. Vradelis, V. Ntelis, K. Thomopoulos, I. Koutroubakis, G. Germanidis, G. Papatheodoridis , K. Soufleris, I. Pachiadakis, I. Goulis, A. Protopapas, K. Paraskeva, C. Mavrogiannis, Y. Kanistras, G. Mantzaris. Poster presentation at the 22nd Panhellenic IBD Congress, Corfu-Greece 2022 (2022)
  • Patient reported outcomes with ustekinumab for Crohn’s Disease in Greece: 12-month interim analysis results of ‘REASSURE’ study. M. Tzouvala, C. Gkamaloutsos, S. Michopoulos, G Bamias, V. Xourgias, D. Christodoulou, C. Liatsos, S. Vradelis, V. Ntelis, K. Thomopoulos, I. Koutroubakis, G. Germanidis, G. Papatheodoridis, K. Soufleris, I. Pachiadakis, I. Goulis, A. Protopapas, K. Paraskeva, C. Mavrogiannis, G. Mantzaris. Oral presentation at the 22nd Panhellenic IBD Congress, Corfu-Greece 2022 (2022)
  • TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY. G. Bamias , G.J. Mantzaris , C. Gkamaloutsos , K. Thomopoulos , M. Tzouvala , I. Koutroubakis , V. Ntelis , C. Liatsos , S. Vradelis , T. Sdonas , G. Papatheodoridis , D.K. Christodoulou , K.D. Paraskeva , I. Goulis , G. Germanidis , V. Xourgias , A. Protopapas , K. Soufleris , I. Pachiadakis , E. Zampeli , I. Kanistras , A. Kekki , S. Michopoulos. E-poster at UEGW 2023, abstract No:1389 (2023)
  • Twelve-month work and activity impairment outcomes in patients with Crohn’s disease treated with ustekinumab in real-world settings in Greece: Interim analysis results of ‘REASSURE’ study. Oral presentation at the 43rd Panhellenic Gastroenterology Congress, Thessaloniki – Greece 2023 (2023)
  • Patient-reported outcomes with ustekinumab for Crohn’s Disease in real-life clinical practice in Greece: final results from the prospective ‘REASSURE’ study. Presented as poster at UEGW 2024 (2024)
  • Persistence to ustekinumab in patients with Crohn’s disease treated in real-life care settings in Greece: final results from the prospective ‘REASSURE’ study. Presented as moderated poster at UEGW 2024 (2024)

Useful Links

Doctoranytime is an end-to-end solution that assists the user from the moment they experience a health symptom until the moment it is resolved, by enabling them to find the specialist they need, request guidance via chat and talk to them via video call. The information provided has been filled in by Γκαμαλουτσος Χρηστος and edited by the doctoranytime team.
Log in or register to continue
Are you a new user? Register for free
Log in or register to continue

Continue with

or register with your email address

The password should contain at least 6 characters and 1 capital letter
Are you a registered user?
Create a new password

Enter the email you used to register in doctoranytime and we'll send you a link to create new password

Your data is in good hands
doctor-graphic doctor-graphic

doctoranytime takes your health as well as your data protection very seriously!

In order to ensure you that:

  • you will continue to get the best possible treatment from the affiliated doctors and diagnostic centers
  • you will continue to book your appointments easily and quickly by having at the same time the right of evaluation
  • we will be able to contact you immediately in case of a change in your appointment
  • you will continue to receive our newsletter and health suggestions that may interest you

it is essential for us to collect and process your personal data to the extent that you allow.

For this reason, we would like to inform you that we take all the necessary measures in order to protect your personal data, according to the New European General Data Protection Regulation (“GDPR”), the terms of the doctoranytime Privacy Policy (that you can read in detail here) and the law requirements.

If you have any questions regarding your privacy protection by doctoranytime or in case you wish to exercise your GDPR rights (information, access, correction, deletion, limitation of processing, portability of your data, objection and right to lodge a complaint with the Personal Data Protection Authority) you can contact the Data Protection Officer of doctoranytime on: [email protected].

Terms of Use

Congratulations!!

Your registration has completed.